Chembio Q1 Revenues More Than Double
Despite the revenue gains, the company said that there is substantial doubt about its ability to continue operations into 2023.
Source: 360dx.com
Stay updated with breaking news from Richard Eberly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite the revenue gains, the company said that there is substantial doubt about its ability to continue operations into 2023.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Which penny stocks are you watching right now?
Hot penny stocks to watch as new virus fears emerge on Black Friday.
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the